1. Shah Siddharth N
2. Mittal Naveen
3. Maheshwari Ragini

9789390020683

10.5005/jp/books/18355_62

1/e

2020

2

1. University of Mumbai, Consulting Physician and Diabetologist, SL Raheja Hospital and All India Institute of Diabetes, Saifee Hospital, Bhatia Hospital, Sir Hurkisondas, N Hospital, Mumbai, Maharashtra, India, University of Mumbai, Consulting Physician and Diabetologist, SL Raheja Hospital and All India Institute, of Diabetes, Saifee Hospital, Bhatia Hospital, Sir Hurkisondas, N Hospital, Mumbai, Maharashtra, India, Bhatia Hospitals, Mumbai, Maharashtra, India, S. L. Raheja Hospital, Bhatia Hospital, and Sir H. N. Hospital, Mumbai, SL Raheja Hospital, Mumbai, Maharashtra, India, Bhatia Hospital, Saifee Hospital; Journal of Association of Physicians of India; API Textbook of Medicine, IX Edition, Mumbai, Maharashtra, India, Mumbai, Maharashtra, India, Bhatia Hospital, Mumbai, Maharashtra, India, Sir HN Reliance Hospital, Bhatia Hospital, SL Raheja Hospital, Saifee Hospital, Global Hospital, Mumbai, Maharashtra, India; JAPI, API Textbook of Medicine, Xth Edition, University of Mumbai; Bhatia, SL Raheja; Saifee,
2. Dayanand Medical College and Hospital, Ludhiana, Punjab, India
3. Rohit Diabetes Centre and Seven Hills Hospital, Mumbai, Maharashtra, India

Sodium-glucose cotransporter-2 inhibitor, urinary tract infection, dipeptidyl peptidase-4, hazard ratio, HR, antidiabetic medication, cardiovascular event